Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
69.35 EUR | +1.31% | -7.31% | -12.91% |
Apr. 10 | CompuGroup Medical SE & Co. KGaA Proposes Dividend for the Year 2023 | CI |
Apr. 04 | Morgan Stanley raises Compugroup to 'Overweight' - Target 37 euros | DP |
Sales 2024 * | 1.25B 1.33B | Sales 2025 * | 1.3B 1.39B | Capitalization | 1.53B 1.63B |
---|---|---|---|---|---|
Net income 2024 * | 94M 100M | Net income 2025 * | 118M 126M | EV / Sales 2024 * | 1.74 x |
Net Debt 2024 * | 632M 674M | Net Debt 2025 * | 544M 580M | EV / Sales 2025 * | 1.59 x |
P/E ratio 2024 * |
16.2
x | P/E ratio 2025 * |
13
x | Employees | - |
Yield 2024 * |
2.05% | Yield 2025 * |
2.35% | Free-Float | 46.87% |
Latest transcript on CompuGroup Medical Societas Europaea
1 day | +1.31% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Rauch
CEO | Chief Executive Officer | 52 | 19-07-31 |
Frank Gotthardt
CEO | Chief Executive Officer | 72 | 86-12-31 |
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Gotthardt
BRD | Director/Board Member | - | 03-08-21 |
Director/Board Member | 59 | 20-06-17 | |
Klaus Esser
BRD | Director/Board Member | - | 03-05-25 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.56% | 332B | |
+20.99% | 210B | |
+4.24% | 153B | |
+12.97% | 55.95B | |
+9.11% | 32.12B | |
-0.92% | 28.65B | |
+88.10% | 22.12B | |
+17.99% | 18.86B | |
-2.52% | 14.47B |
- Stock Market
- Equities
- COP Stock
- COP Stock